The short version
7 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 34% in a year, to $62.35 per mL — and generics that get this cheap tend to get abandoned rather than defended. A Class II recall hit this product in the past year (Lupin Pharmaceuticals Inc.). Put together: worth watching — several of the pressures that precede supply trouble are present at once. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.